The health ministry is unlikely to extend the Schedule M deadline for MSME pharma firms beyond December 31, 2025, as it ...
Low compliance by the country’s 8,500 small and medium enterprises (MSMEs) manufacturing pharmaceuticals would raise the risk ...
ET Now on MSN
Exclusive | Dr Reddy's USFDA 5 observations from Srikakulam plant: Details from Form 483
Dr Reddy's Laboratories informed the stock exchanges on December 12, 2025, about the conclusion of the inspection.
In order to usher in domestic & global regulatory compliance in pharma sector under the current revised Schedule M regime in India, cGxP Lifeline hosted its first Annual Conference 2025 in Mumbai ...
GMP in Bury has warned residents of Whitefield to check their post carefully because of a rise in the seizures of parcels coming into the UK.
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) on Monday announced program updates on TNX-4800 (formerly known as mAb 2217LS), a long-acting human monoclonal antibody (mAb) that targets the outer ...
Comprehensive Ingredient Analysis and Clinical Study References Compiled as Post-Holiday Search Interest in Natural ...
Next-generation biologics, such as bispecifics, fusion proteins, and multi-specifics, have multiple functionalities that ...
TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...
Harbour BioMed inks long-term strategic collaboration with Lannacheng to advance next-generation radionuclide drug conjugates: Shanghai, China Tuesday, December 30, 2025, 13:00 Hr ...
A group of consumer advocate organizations has asked top health officials to take immediate action to protect the safety of ...
Strides Pharma Science Ltd's Chestnut Ridge facility received four procedural FDA observations, with no impact on supply.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results